MUSCARINIC RECEPTOR-BINDING AND ACTIVATION OF 2ND MESSENGERS BY SUBSTITUTED N-METHYL-N-[4-(1-AZACYCLOALKYL)-2-BUTYNYL]ACETAMIDES

被引:0
|
作者
BRADBURY, BJ
BAUMGOLD, J
PAEK, R
KAMMULA, U
ZIMMET, J
JACOBSON, KA
机构
[1] NIDDK,CHEM LAB,BETHESDA,MD
[2] GEORGE WASHINGTON UNIV,DEPT RADIOL,WASHINGTON,DC 20052
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
引用
收藏
页码:24 / MEDI
相关论文
共 50 条
  • [41] Rational design, synthesis, SAR study of N-napthalen-1-yl-2-[4-(substituted phenyl)-piperazin-1-yl]-acetamides as atypical antipsychotic agents
    Sati, N.
    Kumar, S.
    Rawat, M. S. M.
    INDIAN JOURNAL OF CHEMISTRY SECTION B-ORGANIC CHEMISTRY INCLUDING MEDICINAL CHEMISTRY, 2012, 51 (01): : 318 - 322
  • [42] SYNTHESIS AND RECEPTOR-BINDING OF ENANTIOMERIC N-SUBSTITUTED CIS-N-[2-(3,4-DICHLOROPHENYL)ETHYL]-2-(1-PYRROLIDINYL)CYCLOHEXYLAMINES AS HIGH-AFFINITY SIGMA RECEPTOR LIGANDS
    RADESCA, L
    BOWEN, WD
    DIPAOLO, L
    DECOSTA, BR
    JOURNAL OF MEDICINAL CHEMISTRY, 1991, 34 (10) : 3058 - 3065
  • [43] N-[(1-cyclopropylmethyl-2-pyrrolidinyl)methyl]-substituted benzamides:: Synthesis and dopamine D-2 and D-3 receptor binding affinities
    Yang, ZY
    Mukherjee, J
    MEDICINAL CHEMISTRY RESEARCH, 1999, 9 (01) : 1 - 8
  • [44] SYNTHESIS AND RECEPTOR-BINDING STUDIES RELEVANT TO THE NEUROLEPTIC ACTIVITIES OF SOME 1-METHYL-4-PIPERIDYLIDENE-9-SUBSTITUTED-PYRROLO[2,-B][3]BENZAZEPINE DERIVATIVES
    REMY, DC
    BRITCHER, SF
    KING, SW
    ANDERSON, PS
    HUNT, CA
    RANDALL, WC
    BELANGER, P
    ATKINSON, JG
    GIRARD, Y
    ROONEY, CS
    FUENTES, JJ
    TOTARO, JA
    ROBINSON, JL
    RISLEY, EA
    WILLIAMS, M
    JOURNAL OF MEDICINAL CHEMISTRY, 1983, 26 (07) : 974 - 980
  • [45] N-[H-3]METHYLSCOPOLAMINE LABELING OF NON-M1, NON-M2 MUSCARINIC RECEPTOR-BINDING SITES IN RAT-BRAIN
    SMITH, TD
    ANNIS, SJ
    EHLERT, FJ
    LESLIE, FM
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1991, 256 (03): : 1173 - 1181
  • [46] Synthesis and Positive Inotropic Evaluation of 2-(4-(4-Substituted benzyloxy)-3-methoxybenzyl)-1,4-diazepan-1-yl)-N-(4,5-dihydro-1-methyl[1,2,4]triazolo[4,3-a]quinolin-7-yl)-acetamides
    Li, Jing-Yuan
    Cui, Xun
    Liu, Xue-Kun
    Hong, Lan
    Quan, Zhe-Shan
    Piao, Hu-Ri
    ARCHIV DER PHARMAZIE, 2008, 341 (12) : 794 - 799
  • [47] N-(4-(4-(2-halogenophenyl)piperazin-1-yl)butyl) substituted cinnamoyl amide derivatives as dopamine D2 and D3 receptor ligands
    Saur, Oliver
    Hackling, Anneke E.
    Perachon, Sylvie
    Schwartz, Jean-Charles
    Sokoloff, Pierre
    Stark, Holger
    ARCHIV DER PHARMAZIE, 2007, 340 (04) : 178 - 184
  • [48] Enantiomeric N-methyl-4-piperidyl benzilates as muscarinic receptor ligands:: Radioligand binding studies and docking studies to models of the three muscarinic receptors M1, M2 and M3
    Selent, J
    Brandt, W
    Pamperin, D
    Göber, B
    BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (06) : 1729 - 1736
  • [49] Synthesis of 2-substituted-N-[4-(1-methyl-4,5-diphenyl-1H-imidazole-2-yl) phenyl]acetamide derivatives and evaluation of their anticancer activity
    Ozkay, Yusuf
    Isikdag, Ilhan
    Incesu, Zerrin
    Akalin, Guelsen
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2010, 45 (08) : 3320 - 3328
  • [50] Effect of α-N-methylation of residues in the receptor-binding region of hPTH(1-31)NH2 on structure and adenylyl cyclase activation.
    Willick, GE
    Barbier, J
    MacLean, S
    Whitfield, JF
    JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 : S176 - S176